US › Healthcare

Addex Therapeutics Ltd (ADXN)

US · Healthcare · Biotechnology

$2.76-8.61%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$9,908

Revenue YoY

-72.8%

Net profit

$-1.7M

EPS

$-2.16

Net margin

-17,543.0%

Key statistics

Market cap

$4.6M

Forward P/E

0.0

P/B

1.09

Book value

$2.16

EPS (TTM)

$-7.56

52-week high

$11.97

52-week low

$2.56

50-day MA

$4.05

200-day MA

$6.13

Beta

2.02

Analyst view

with an average price target of $30.00.

Shareholding

Institutions

0.01%

Largest institutional holders

Fund	Stake
UBS Group AG	0.00%
SBI Securities Co Ltd	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Rhumbline Advisers	0.00%
GAMMA Investing LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Addex Therapeutics Ltd — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.